European Heart Journal

The European Heart Journal, published by Oxford University Press on behalf of the European Society of Cardiology, stands as one of the most authoritative and influential journals in cardiovascular medicine. With a 2026 Impact Factor of 45.3000 and consistently ranked in the JCR Q1 quartile, it occupies the highest tier of clinical and scientific publications in its field. The journal’s scope encompasses the entire spectrum of cardiovascular science, from basic molecular mechanisms to population-based epidemiology, with a strong emphasis on translational research and clinical practice. Its main topics include coronary artery disease, heart failure, arrhythmias, valvular heart disease, hypertension, vascular biology, and interventional cardiology, alongside emerging areas such as cardio-oncology, precision medicine, and cardiovascular imaging. The journal publishes a diverse range of article types, including original research articles, rapid communications, comprehensive review articles, state-of-the-art reviews, clinical trial updates, and editorial discussions. It also features dedicated sections for ESC Guidelines and consensus documents, which serve as global benchmarks for clinical care. The target audience comprises cardiologists, internists, cardiovascular surgeons, researchers, and healthcare professionals seeking cutting-edge evidence and authoritative guidance. Notable features include a rigorous double-blind peer-review process, a fast-track option for high-impact findings, and open access options for authors who wish to maximize dissemination. Its editorial board comprises leading international experts, and the journal maintains a strong digital presence with podcasts, video abstracts, and an active social media strategy. The European Heart Journal is widely regarded as the premier venue for landmark cardiovascular research, and its exceptional impact factor underscores its dominance as the top-cited journal in cardiology worldwide.